Patents - Global Data - Dimensions
EFFECTIVE DOSES OF CNP CONJUGATES
Applicants:
- Ascendis Pharma Growth Disorders AS [NORA names: Ascendis Pharma; Private Research]
- Ascendis Pharma Endocrinology Division AS
Abstract
The present invention relates to unit dosage forms comprising a CNP conjugate or pharmaceutically acceptable salt thereof.
Patent Family Records (3)
EFFECTIVE DOSES OF CNP CONJUGATES
Ascendis Pharma Growth Disorders AS SPROGØE KENNETT, KJELGAARD-HANSEN MADS JENS
2024, AU-2022413318-A1
EFFECTIVE DOSES OF CNP CONJUGATES
ASCENDIS PHARMA GROWTH DISORDERS AS SPROGØE KENNETT, KJELGAARD-HANSEN MADS JENS
2023, WO-2023110758-A1
EFFECTIVE DOSES OF CNP CONJUGATES
Ascendis Pharma Growth Disorders AS SPROGOE KENNETT, KJELGAARD-HANSEN MADS JENS
2023, CA-3236278-A1
